Ra Medical Systems CEO resigns
19 Apr 2023
Executive Change
The resignation will take effect on April 28. He will also resign from his position on the board of directors of the electrophysiology procedures tech company.
Ra Medical’s board of directors has established a committee for examining a transition at the CEO level. David Jenkins, executive chair of the board, will serve as interim CEO until a full-time replacement is named.
McGuire has served at CEO of the company since April 2020. Prior to joining Ra MedicalRa Medical, he was president and CEO of Second Sight Medical. He has also held numerous leadership roles in the medtech industry at Covidien, AtheroMed, Guidant and Spectranetics.
Earlier this year, Ra Medical completed a merger with Catheter Precision. As part of the deal, the combined company realigned its board of directors. Jenkins joined the board as executive chair, and James Caruso was appointed as a director. Martin Colombatto, McGuire and Susann Meline were appointed as directors. Additionally, directors Joan Stafslien and Richard Mejia resigned.
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Indications
Targets
-Drugs
-Chat with Hiro
Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.